Abstract
Background: Boronic acid as a medicinal agent, owing to low aqueous solubility and cellular uptake has been restricted in many curcumin analogues with potential anticancer activity. This study aimed to evaluate the cytotoxicity effect of CCB-4 [a curcumin derivative contain boron with a methylpiperidone core], CCB-4-N-methylglucamine (CCB-4 MG) complex in breast cancer cell lines, and also to enhance the aqueous solubility of CCB-4 by complexation with N-methylglucamine (MG) and then to evaluate its cellular uptake and microdistribution in MCF-7 cells.
Methods: CCB-4 was synthesized using Claisen–Schmidt condensation and was fully characterized by IR, HR-MS, 1D/2D NMR. Complex formation of CCB-4 with MG were achieved through boronic acid–diol interaction. The physicochemical properties, aqueous solubility, cytotoxicity, inhibitions of colony formation and cellular uptake, retention boron and intracellular microdistribution were determined in MCF-7 breast cancer cells.
Results: CCB-4 was synthesized with 70% yield and confirmed structural integrity. The CCB-4 MG complex provided a homogeneous system with enhanced colloidal stability and 25.14-fold increase in aqueous solubility over free CCB-4. The CCB-4 MG complex had greater cytotoxic activity, substantial inhibition of colony formation, high cellular boron uptake and long-term retention in the intracellular environment and was predominantly located in the cytoplasm of MCF-7 cells.
Conclusion: MG significantly increased the solubility, cellular uptake and anticancer efficacy of CCB-4, suggesting its potential to optimize therapeutic performance of curcumin analogues based on boronic acid in breast cancer therapy.